Revenue
2021
2022
2023
2024
2025
Cardio Diagnostics Holdings, Inc. (CDIO)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $14,825 | $34,890 | $17,065 | $950 | $901 |
| Research & development | $641,212 | $227,966 | $145,182 | $40,448 | $31,468 |
| Operating expenses | $6.5M | $8.4M | $7.3M | $4.5M | $621,349 |
| Operating income | −$6.5M | −$8.4M | −$7.2M | −$4.5M | −$620,448 |
| EBITDAderived | −$6.4M | −$8.3M | −$7.2M | −$4.5M | −$604,448 |
| Net income | −$6.5M | −$8.4M | −$8.4M | −$4.7M | −$620,448 |
| Basic EPSper diluted share | -$3.71 | -$9.35 | -$0.66 | -$1.51 | -$0.53 |
| Diluted EPSper diluted share | -$3.71 | -$9.35 | -$0.66 | -$1.51 | -$0.53 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Sep 6, 2024Form 4/A | Dogan TimurChief Technology Officer | BuyCommon Stock | 69.0K | $0.29 | $20.0K | 197.3K |
| Sep 6, 2024Form 4/A | Dogan MeeshanthiniChief Executive Officer | BuyCommon Stock | 69.0K | $0.29 | $20.0K | 1.66M |
| Sep 6, 2024Form 4/A | Dogan MeeshanthiniChief Executive Officer | BuyCommon Stock | 69.0K | $0.29 | $20.0K | 1.66M |
| Sep 6, 2024Form 4/A | Dogan TimurChief Technology Officer | BuyCommon Stock | 69.0K | $0.29 | $20.0K | 197.3K |
| Sep 6, 2024Form 4 | Philibert RobertChief Medical Officer | BuyCommon Stock · indirect | 7.5K | $0.28 | $2.1K | 1.68M |